Journal of the American College of Nutrition, Vol 14, Issue 4 317-324, Copyright © 1995 by American College of Nutrition

JOURNAL ARTICLE

Asthma and oxidant stress: nutritional, environmental, and genetic risk factors

L. S. Greene
Department of Anthropology, University of Massachusetts/Boston 02125-3393, USA.

A considerable body of evidence suggests that oxidant stress results in inflammation and tissue damage in the respiratory system, and later in immune damage, and that individuals with lowered cellular reducing capacity are at increased risk to develop asthma. Reducing capacity in the erythrocyte is generated through the pentose phosphate pathway and this pathway also generates a major portion of the reducing capacity in all cells of the body. Therefore, dietary, environmental, and genetic factors which diminish cellular reducing capacity will increase tissue vulnerability to oxidant stress and are likely to increase asthma risk. Dietary selenium deficiency lowers red cell glutathione peroxidase activity and is associated with an increased risk for asthma, and low dietary intakes of vitamins C and E also appear to increase asthma risk. High body iron stores increase free radical production and may also elevate asthma risk. Environmental lead exposure depresses the activities of a several enzyme systems that influence cellular reducing capacity (glucose-6-phosphate dehydrogenase, NAD synthetase, glutathione peroxidase, superoxide dismutase, catalase) and consequently may increase asthma risk. Genetically-determined low activity of glucose-6-phosphate dehydrogenase lowers cellular reducing capacity and may also heighten asthma risk. Simple dietary and environmental interventions may significantly reduce oxidant stress and prevent or minimize the development of asthmatic symptoms and should prove to be a cost effective approach to asthma management in addition to current pharmacological strategies.

This article has been cited by other articles:

				T. Islam, R. McConnell, W. J. Gauderman, E. Avol, J. M. Peters, and F. D. Gilliland Ozone, Oxidant Defense Genes, and Risk of Asthma during Adolescence Am. J. Respir. Crit. Care Med., February 15, 2008; 177(4): 388 - 395. [Abstract] [Full Text] [PDF]

				H. C. Jeong, S. Y. Lee, E. J. Lee, K. H. Jung, E. H. Kang, S. Y. Lee, J. H. Kim, E. K. Park, S. H. Lee, C. S. Uhm, et al. Proteomic Analysis of Peripheral T-Lymphocytes in Patients With Asthma Chest, August 1, 2007; 132(2): 489 - 496. [Abstract] [Full Text] [PDF]

				G. Riccioni, M. Barbara, T. Bucciarelli, C. di Ilio, and N. D'Orazio Antioxidant Vitamin Supplementation in Asthma Ann. Clin. Lab. Sci., January 1, 2007; 37(1): 96 - 101. [Abstract] [Full Text] [PDF]

				Y.-L. Lee, T.-R. Hsiue, Y.-C. Lee, Y.-C. Lin, and Y. L. Guo The Association Between Glutathione S-Transferase P1, M1 Polymorphisms and Asthma in Taiwanese Schoolchildren Chest, September 1, 2005; 128(3): 1156 - 1162. [Abstract] [Full Text] [PDF]

				P. Knekt, J. Kumpulainen, R. Jarvinen, H. Rissanen, M. Heliovaara, A. Reunanen, T. Hakulinen, and A. Aromaa Flavonoid intake and risk of chronic diseases Am. J. Clinical Nutrition, September 1, 2002; 76(3): 560 - 568. [Abstract] [Full Text] [PDF]

				A. A. FRYER, A. BIANCO, M. HEPPLE, P. W. JONES, R. C. STRANGE, and M. A. SPITERI Polymorphism at the Glutathione S-transferase GSTP1 Locus . A New Marker for Bronchial Hyperresponsiveness and Asthma Am. J. Respir. Crit. Care Med., May 1, 2000; 161(5): 1437 - 1442. [Abstract] [Full Text]

				A. Singhal, R. Morley, R. Abbott, S. Fairweather-Tait, T. Stephenson, and A. Lucas Clinical Safety of Iron-Fortified Formulas Pediatrics, March 1, 2000; 105(3): 38e - 38. [Abstract] [Full Text]

				P. J. Barnes, K. F. Chung, and C. P. Page Inflammatory Mediators of Asthma: An Update Pharmacol. Rev., December 1, 1998; 50(4): 515 - 596. [Abstract] [Full Text] [PDF]